The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer - Wikidata - awgldk - TriplyDB

The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer

The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer

http://www.wikidata.org/entity/Q28283868

about

The insights of Let-7 miRNAs in oncogenesis and stem cell potency Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential PAK signalling during the development and progression of cancer Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities.The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel.Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedb MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large Reduced expression levels of let-7c in human breast cancer patients.MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.Protein tyrosine phosphatase-PEST and β8 integrin regulate spatiotemporal patterns of RhoGDI1 activation in migrating cells MicroRNA expression profiling of the developing murine upper lip.Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer RBMMMDA: predicting multiple types of disease-microRNA associations.Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics.High DRC Levels Are Associated with Let-7b Overexpression in Women with Breast Cancer.Non-coding RNAs and cancer.Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers.miR-494-3p is a novel tumor driver of lung carcinogenesis.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.Enhanced Identification of Potential Pleiotropic Genetic Variants for Bone Mineral Density and Breast Cancer.Breast cancer stem cells programs: enter the (non)-code.Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7.MiRNA let-7g regulates skeletal myoblast motility via Pinch-2.Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levels.Mutual enrichment in aggregated ranked lists with applications to gene expression regulation.A TALEN-based strategy for efficient bi-allelic miRNA ablation in human cells Anoikis resistance and oncoviruses.Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma.let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery.The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.MicroRNA hsa-let-7e-5p as a potential prognosis marker for rectal carcinoma with liver metastases.MicroRNA and Breast Cancer: Understanding Pathogenesis, Improving Management.Endogenous reference RNAs for microRNA quantitation in formalin-fixed, paraffin-embedded lymph node tissue.MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

P2860

Q26751493-7AB9B870-8215-4AD2-B530-5668E905C3F9 Q26772219-37B821EA-D3AA-42A7-AA9D-5815C705F0D1 Q28079848-C85CCB83-0287-490D-A2D0-7DCBC6BD4ED3 Q28081081-754E6B87-9AF4-4196-8D86-E722790B2F34 Q28307460-5C5C3F9B-ECBD-494A-B1B9-53C1922A1686 Q28390359-7955E3D9-53A2-4E13-9511-B2995CF9D420 Q31036763-B543C006-C7CC-467E-88F6-F7507D086D52 Q33649015-13B79C8D-27D1-478D-B3FC-C2B51E6A152D Q33724231-F045A6A0-D0F9-4193-8E2F-8453C3E9973F Q34066078-8EA61C5B-0B86-4A73-86A5-31894EA4BCDE Q34537320-16B30A44-73D1-4873-B527-444DEC81C1F1 Q34584221-5468FC98-1C3A-4516-A138-3C9C0A96B773 Q35042277-A9DE4276-B15B-4B09-B9B5-9445A3D950B2 Q35201698-74FC00EE-B2AA-4BD2-80B8-C1F6FF35619E Q35214716-958F6296-AD2B-4343-A816-68AF517FAE06 Q35231639-20F489F8-4FE3-4E76-BC48-F0D6E68B3082 Q35881362-311B2D87-089B-4552-B548-968FE5FB69F2 Q36034189-EC4A4C7F-DBBE-44B9-BD61-0662AC71317A Q36593659-5DBBB026-591B-4DB2-9827-023674791F54 Q37050612-8952CFA4-17ED-4348-B80E-8770BAC4ED9D Q37139278-EDE8C178-63FB-42AC-B5F5-6D538C59A3C9 Q37658419-79AF8B70-9193-47B6-A518-293FBBD71C70 Q37702495-5144C342-F5DC-4462-8709-ABD2C0FA337D Q38336073-FE617E10-2789-4216-90F6-4F5DB5263D97 Q38650160-C0ADD258-4BDC-4B18-9233-4AB71AA13F82 Q38765793-04F5E4F9-A896-4978-896E-BD8C2F620360 Q38785460-6704D77A-6293-4A3D-A454-81FEE32C1D86 Q38842480-F3DC79B0-508C-4228-A858-2FC387F1066F Q39016873-8F350A19-0380-4FB8-B5B5-D7066EC959FC Q39053707-0BA0E924-B5C6-4D4B-9DFD-D5590D4FCE28 Q39429443-47BB8C6B-66D6-4F64-A2F6-9F95A11816F1 Q39704645-9B7686CF-A896-4147-A9FC-74A5F6693D76 Q40072469-50F3778B-B2D1-48E9-ACED-A86BF0AAD4B6 Q41390560-7F823398-38AE-4475-B0E2-5D7DB418A476 Q47134084-6012ED70-A7C2-46BD-AA46-C28240148594 Q49593660-05B136D8-3415-4FC2-8AC5-0610BA2CE24D Q54112022-FF2B33A4-2D61-457E-B276-945E6170D529 Q54944098-61C27A08-658B-41B9-B970-49080C83045D Q55001422-805F5309-6194-4401-8E80-BB6D2170CDAE Q55518168-77CC429A-442D-45BE-B342-F45163FDFA13

P2860

The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer

http://www.wikidata.org/entity/Q28283868

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The heterochronic microRNA let ...... leton pathway in breast cancer

@ast

The heterochronic microRNA let ...... leton pathway in breast cancer

@en

The heterochronic microRNA let ...... leton pathway in breast cancer

@nl

type

label

The heterochronic microRNA let ...... leton pathway in breast cancer

@ast

The heterochronic microRNA let ...... leton pathway in breast cancer

@en

The heterochronic microRNA let ...... leton pathway in breast cancer

@nl

prefLabel

The heterochronic microRNA let ...... leton pathway in breast cancer

@ast

The heterochronic microRNA let ...... leton pathway in breast cancer

@en

The heterochronic microRNA let ...... leton pathway in breast cancer

@nl

P1433

Q28283868-A72AF746-ED79-4476-A616-B4C9674F1E2A

P1476

Q28283868-0C91B086-0361-4025-9A5C-2FE46113EC7D

P2093

Q28283868-1259A437-ADFB-4E78-BF40-0196175CEBD8

Q28283868-2684FE26-F524-484B-93D5-63B8304D2B10

Q28283868-3F91C022-BDDB-45DB-AF11-0157094D2419

Q28283868-77649FD2-A382-4139-BD15-433A119DE0CD

Q28283868-7B5E577E-C147-4F27-ADC5-88721684C6D2

Q28283868-8592BE29-ACF3-4A3B-86FE-3B08E284E7A5

Q28283868-B5CCA8ED-9122-46B2-9AAE-D75826F348C7

Q28283868-B82F9DC7-C225-435E-A86F-CA7378A3628A

Q28283868-C193EF2D-7CE1-44C8-A0C8-8CA8B6B70B4C

Q28283868-C61293E4-81E9-4581-9051-625DC6DD32D8

P2860

Q28283868-0EBB28FE-66C1-42CD-BE22-68864FA7377F

Q28283868-13835BAC-038E-4724-9673-8BF026EFA15C

Q28283868-150B98D6-A75A-413F-A979-BE72EFAD8C33

Q28283868-2226D24D-60BB-4774-98B9-44795F22FF2B

Q28283868-239385D4-5C66-4B00-9F10-C5DE9408AD95

Q28283868-247BD7BB-DCB5-4F0A-9993-DDB26F1A453D

Q28283868-2728A519-5A6D-473D-BA66-811FD81AD289

Q28283868-2A755ACD-703F-490A-87E9-25482E6DD444

Q28283868-30C9F359-2154-4861-8D40-CCC4C972A821

Q28283868-322C5105-9186-4E38-A1A8-2DCCD6C462A7

P304

Q28283868-654A6B61-DDBF-4CBE-8A70-7DB74481EA71

P31

Q28283868-E1E914BD-3333-4FDF-AFD2-9353FE95124C

P3181

Q28283868-F4361EC0-DAC5-49F0-B49B-263352F17211

P356

Q28283868-DB527B08-A60B-4BA8-A469-9474018BE2A6

P407

Q28283868-D52125D4-F137-47E3-A2D9-801A1BAC8423

P433

Q28283868-D2C4D1DC-BE0A-48D8-8972-E30065B96F22

P478

Q28283868-DFEDF02B-BC1F-4539-AAB0-7B6985B66E1E

P50

Q28283868-B55BC5EA-97CD-4251-BCDA-692A3F23A0B3

P577

Q28283868-7E2B35E6-997C-4F0A-BA0D-025B0BCC7194

P698

Q28283868-887120F1-899D-4606-9316-B506DF2BCF5F

P921

Q28283868-158E0C8A-F94B-4E21-908B-DDE0F7DA3640

Q28283868-83BEF597-6002-46FE-BF77-ED309A1F8EC6

Q28283868-CB39F7BA-F915-4C06-81FE-0DB356A2FB9B

P932

Q28283868-8FB0635D-C98E-424A-8510-C32E4C60DD09

P3181

P356

1541-7786.MCR-12-0432

P1433

Molecular Cancer Research

P1476

The heterochronic microRNA let ...... leton pathway in breast cancer

@en

P2093

Chunsheng Li

http://www.w3.org/2001/XMLSchema#string

Dionyssios Katsaros

http://www.w3.org/2001/XMLSchema#string

Janos L Tanyi

http://www.w3.org/2001/XMLSchema#string

Jinyi Guo

http://www.w3.org/2001/XMLSchema#string

Lan Zheng

http://www.w3.org/2001/XMLSchema#string

Lin Zhang

http://www.w3.org/2001/XMLSchema#string

Marco Mitidieri

http://www.w3.org/2001/XMLSchema#string

Qihong Huang

http://www.w3.org/2001/XMLSchema#string

Shun Liang

http://www.w3.org/2001/XMLSchema#string

Tim M Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical outcome prediction by microRNAs in human cancer: a systematic review

Regression of murine lung tumors by the let-7 microRNA

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7

Suppression of non-small cell lung tumor development by the let-7 microRNA family

Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

RAS is regulated by the let-7 microRNA family

Oncomirs - microRNAs with a role in cancer

MicroRNA signatures in human cancers

P304

240-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1098820

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1541-7786.MCR-12-0432

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Chiara Benedetto

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23339187

http://www.w3.org/2001/XMLSchema#string

P921

actin cytoskeleton

P932

3606291

http://www.w3.org/2001/XMLSchema#string